Lancet:全球主要非传染性疾病分析 缺乏身体活动的巨大经济负担

2016-07-29 MedSci MedSci原创

缺乏身体活动与一系列的慢性疾病和过早死亡相关。尽管这是有据可查的疾病负担,但在全球范围内,缺乏运动的经济负担仍然是不可计量的。对经济负担的更好理解可以帮助通知资源的优先性,并鼓励全球范围内为增加运动水平做出努力。 使用标准方法对身体活动相关的直接医疗花费、劳动生产丢失、和伤残调整生命年 (DALYs)进行估计,资源来自142个国家,覆盖全球93.2%的人口的最好数据。在冠心病、卒中、2型糖尿

缺乏身体活动与一系列的慢性疾病和过早死亡相关。尽管这是有据可查的疾病负担,但在全球范围内,缺乏运动的经济负担仍然是不可计量的。对经济负担的更好理解可以帮助通知资源的优先性,并鼓励全球范围内为增加运动水平做出努力。

使用标准方法对身体活动相关的直接医疗花费、劳动生产丢失、和伤残调整生命年 (DALYs)进行估计,资源来自142个国家,覆盖全球93.2%的人口的最好数据。在冠心病、卒中、2型糖尿病乳腺癌结肠癌中估计与缺乏运动相关的直接医疗花费和 DALYs。使用摩擦成本法计算缺乏运动相关死亡导致的生产丢失。分析是基于国家的缺乏身体活动患病率,调整与缺乏身体活动相关的每种疾病的结局和全因死亡的人群归因分数(PAFs) 。

保守估计,2013年世界范围内,因缺乏身体活动导致的医疗花费为538亿美金 (INT$),其中公众部门花费312亿美元,私营部门花费97亿美元,家庭花费97亿美元。另外,缺乏身体活动相关的死亡导致了137亿美元的生产丢失,1340万DALYs。高收入国家承担更高的经济负担 (80.8% 的医疗花费和60.4% 的间接花费),低收入和中等收入国家的疾病负担更重 (75.0% 的DALYs)。敏感性分析基于保守的统计会使估计值更高。

结论:除外发病和过早死亡,缺乏身体活动造成了巨大的经济负担。这篇文章提供了进一步的理由优先促进全球范围内的定期运动,作为减少非传染性疾病的全面战略策略重要组成部分。

原始出处:

Dr Ding Ding, Kenny D Lawson, PhD, et al,The economic burden of physical inactivity: a global analysis of major non-communicable diseases,Lancet,Published Online: 27 July 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1997558, encodeId=3548199e558c1, content=<a href='/topic/show?id=caf4992616a' target=_blank style='color:#2F92EE;'>#非传染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99261, encryptionId=caf4992616a, topicName=非传染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Fri May 05 15:06:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828556, encodeId=a39318285560a, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed May 03 10:06:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911483, encodeId=f72a19114838d, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Jul 06 12:06:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122282, encodeId=82241222827b, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 09:55:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95417, encodeId=e0af9541e83, content=多运动,少吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 01 19:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410659, encodeId=ccc7141065927, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487731, encodeId=1863148e731fa, content=<a href='/topic/show?id=6a40e83665a' target=_blank style='color:#2F92EE;'>#经济负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78366, encryptionId=6a40e83665a, topicName=经济负担)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3e8357293, createdName=bioon6, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95219, encodeId=05519521996, content=厉害的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 31 11:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1997558, encodeId=3548199e558c1, content=<a href='/topic/show?id=caf4992616a' target=_blank style='color:#2F92EE;'>#非传染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99261, encryptionId=caf4992616a, topicName=非传染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Fri May 05 15:06:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828556, encodeId=a39318285560a, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed May 03 10:06:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911483, encodeId=f72a19114838d, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Jul 06 12:06:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122282, encodeId=82241222827b, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 09:55:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95417, encodeId=e0af9541e83, content=多运动,少吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 01 19:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410659, encodeId=ccc7141065927, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487731, encodeId=1863148e731fa, content=<a href='/topic/show?id=6a40e83665a' target=_blank style='color:#2F92EE;'>#经济负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78366, encryptionId=6a40e83665a, topicName=经济负担)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3e8357293, createdName=bioon6, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95219, encodeId=05519521996, content=厉害的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 31 11:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=)]
    2017-05-03 howi
  3. [GetPortalCommentsPageByObjectIdResponse(id=1997558, encodeId=3548199e558c1, content=<a href='/topic/show?id=caf4992616a' target=_blank style='color:#2F92EE;'>#非传染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99261, encryptionId=caf4992616a, topicName=非传染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Fri May 05 15:06:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828556, encodeId=a39318285560a, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed May 03 10:06:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911483, encodeId=f72a19114838d, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Jul 06 12:06:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122282, encodeId=82241222827b, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 09:55:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95417, encodeId=e0af9541e83, content=多运动,少吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 01 19:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410659, encodeId=ccc7141065927, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487731, encodeId=1863148e731fa, content=<a href='/topic/show?id=6a40e83665a' target=_blank style='color:#2F92EE;'>#经济负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78366, encryptionId=6a40e83665a, topicName=经济负担)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3e8357293, createdName=bioon6, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95219, encodeId=05519521996, content=厉害的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 31 11:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=)]
    2017-07-06 xzw113
  4. [GetPortalCommentsPageByObjectIdResponse(id=1997558, encodeId=3548199e558c1, content=<a href='/topic/show?id=caf4992616a' target=_blank style='color:#2F92EE;'>#非传染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99261, encryptionId=caf4992616a, topicName=非传染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Fri May 05 15:06:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828556, encodeId=a39318285560a, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed May 03 10:06:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911483, encodeId=f72a19114838d, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Jul 06 12:06:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122282, encodeId=82241222827b, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 09:55:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95417, encodeId=e0af9541e83, content=多运动,少吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 01 19:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410659, encodeId=ccc7141065927, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487731, encodeId=1863148e731fa, content=<a href='/topic/show?id=6a40e83665a' target=_blank style='color:#2F92EE;'>#经济负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78366, encryptionId=6a40e83665a, topicName=经济负担)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3e8357293, createdName=bioon6, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95219, encodeId=05519521996, content=厉害的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 31 11:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=)]
    2016-09-11 1e10c84am36(暂无匿称)

    己拜读,受益匪浅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1997558, encodeId=3548199e558c1, content=<a href='/topic/show?id=caf4992616a' target=_blank style='color:#2F92EE;'>#非传染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99261, encryptionId=caf4992616a, topicName=非传染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Fri May 05 15:06:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828556, encodeId=a39318285560a, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed May 03 10:06:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911483, encodeId=f72a19114838d, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Jul 06 12:06:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122282, encodeId=82241222827b, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 09:55:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95417, encodeId=e0af9541e83, content=多运动,少吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 01 19:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410659, encodeId=ccc7141065927, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487731, encodeId=1863148e731fa, content=<a href='/topic/show?id=6a40e83665a' target=_blank style='color:#2F92EE;'>#经济负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78366, encryptionId=6a40e83665a, topicName=经济负担)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3e8357293, createdName=bioon6, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95219, encodeId=05519521996, content=厉害的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 31 11:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=)]
    2016-08-01 忠诚向上

    多运动,少吃

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1997558, encodeId=3548199e558c1, content=<a href='/topic/show?id=caf4992616a' target=_blank style='color:#2F92EE;'>#非传染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99261, encryptionId=caf4992616a, topicName=非传染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Fri May 05 15:06:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828556, encodeId=a39318285560a, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed May 03 10:06:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911483, encodeId=f72a19114838d, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Jul 06 12:06:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122282, encodeId=82241222827b, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 09:55:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95417, encodeId=e0af9541e83, content=多运动,少吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 01 19:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410659, encodeId=ccc7141065927, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487731, encodeId=1863148e731fa, content=<a href='/topic/show?id=6a40e83665a' target=_blank style='color:#2F92EE;'>#经济负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78366, encryptionId=6a40e83665a, topicName=经济负担)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3e8357293, createdName=bioon6, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95219, encodeId=05519521996, content=厉害的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 31 11:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1997558, encodeId=3548199e558c1, content=<a href='/topic/show?id=caf4992616a' target=_blank style='color:#2F92EE;'>#非传染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99261, encryptionId=caf4992616a, topicName=非传染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Fri May 05 15:06:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828556, encodeId=a39318285560a, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed May 03 10:06:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911483, encodeId=f72a19114838d, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Jul 06 12:06:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122282, encodeId=82241222827b, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 09:55:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95417, encodeId=e0af9541e83, content=多运动,少吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 01 19:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410659, encodeId=ccc7141065927, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487731, encodeId=1863148e731fa, content=<a href='/topic/show?id=6a40e83665a' target=_blank style='color:#2F92EE;'>#经济负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78366, encryptionId=6a40e83665a, topicName=经济负担)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3e8357293, createdName=bioon6, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95219, encodeId=05519521996, content=厉害的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 31 11:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1997558, encodeId=3548199e558c1, content=<a href='/topic/show?id=caf4992616a' target=_blank style='color:#2F92EE;'>#非传染性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99261, encryptionId=caf4992616a, topicName=非传染性疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8994206, createdName=chendoc242, createdTime=Fri May 05 15:06:00 CST 2017, time=2017-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828556, encodeId=a39318285560a, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Wed May 03 10:06:00 CST 2017, time=2017-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1911483, encodeId=f72a19114838d, content=<a href='/topic/show?id=77b3259009f' target=_blank style='color:#2F92EE;'>#传染性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25900, encryptionId=77b3259009f, topicName=传染性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2317301, createdName=xzw113, createdTime=Thu Jul 06 12:06:00 CST 2017, time=2017-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=122282, encodeId=82241222827b, content=己拜读,受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Sun Sep 11 09:55:00 CST 2016, time=2016-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95417, encodeId=e0af9541e83, content=多运动,少吃, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Mon Aug 01 19:44:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410659, encodeId=ccc7141065927, content=<a href='/topic/show?id=f22193211c8' target=_blank style='color:#2F92EE;'>#身体活动#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93211, encryptionId=f22193211c8, topicName=身体活动)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=746d2763332, createdName=smlt2009, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487731, encodeId=1863148e731fa, content=<a href='/topic/show?id=6a40e83665a' target=_blank style='color:#2F92EE;'>#经济负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78366, encryptionId=6a40e83665a, topicName=经济负担)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3e8357293, createdName=bioon6, createdTime=Sun Jul 31 12:06:00 CST 2016, time=2016-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95219, encodeId=05519521996, content=厉害的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Jul 31 11:14:00 CST 2016, time=2016-07-31, status=1, ipAttribution=)]
    2016-07-31 oo902

    厉害的研究

    0

相关资讯

2015年度糖尿病领域全球20大关键进展

IDF指出,目前全球有4.15亿糖尿病成年患者,3.18亿人存在患糖尿病的风险(IDF 2015:全世界共有4.15亿成年人患有糖尿病,中国1.1亿人)。大多数国家5%-20%的医疗预算花在糖尿病上,IDF预计至2040年每十个人中将有一人患糖尿病。2型糖尿病占全球所有糖尿病病例的90%,该疾病与不健康的生活方式密切相关。转眼间2015年已经接近尾声,MedSci为大家盘点这一年来糖尿病领域的最新

重磅:2015年度全球高被引科学家正式出炉!

今天,汤森路透旗下的知识产权与科技事业部正式发布了《2015年全球最具影响力的科研精英》研究报告,其通过引文分析揭示各学科领域被同行认为在全球最具影响力的“高被引科学家”,本期我们就来看一看2015年度中国大陆地区的全球高被引科学家。 作为一项受到全球学术界广泛认可的长期研究,《2015年全球最具影响力的科研精英》(即“高被引科学家” 研究报告)甄选出了近3,000位科研人员,这些科研人员发表的

Circulation:全球房颤数据差异惊人

2014年1月24日,Circulation杂志在线发表了RE-LY房颤注册研究结果,来自46个国家急诊室的心房颤动患者在危险因素和治疗方面的差异十分显著。【原文下载】论文的主要作者、瑞典乌普萨拉大学的Jonas Oldgren博士说,RE-LY AF研究显示,通过对全球随机临床试验和基于北美和西欧社区的研究的比较发现,房颤具有完全不同的年龄、危险因素和并发症模式。这项研究

Lancet Respir Med:全球耐药肺结核防治(综述)

广泛耐药性肺结核主要影响从事经济活动的年轻人,具有较高的死亡率,其出现引发了全球的健康危机。在一些国家,如南非, 耐药性肺结核占肺结核病例的3%,却消耗了全国肺结核总预算的1/3以上,该不可持续状况给国家肺结核规划的稳定性带来威胁。然而,谈耐多药结核病色变,特别是完全耐药肺结核和极度耐药肺结核,这两种肺结核耐所有或几乎所有的传统一线和二线抗结核药物。在本综述中,作者讨论了肺结核的流行

Lancet:全球疾病负担报告2013

《柳叶刀》杂志近日公布了“全球疾病负担报告2013”。该研究评估了1990年~2013年间188个国家的死亡情况。文章中特别指出,与2010年的报告相比,新报告主要是中国提供了新的数据。 根据报告,1990年全球人群预期寿命为65.3岁,2013年增长到了71.5岁,平均长了6岁。 寿命延长肯定是疾病病死率下降的结果,但文章指出,高收入地区和低收入地区病死率下降是不同的。在高收入地区,癌症下降